Violari A. Paed F.C. Lindsey J.C. Hughes M.D. Mujuru H.A. Barlow-Mosha L. Kamthunzi P. Chi B.H. Cotton M.F. Moultrie H. Khadse S. Schimana W. Bobat R. Purdue L. Eshleman S.H. Abrams E.J. Millar L. Petzold E. Mofenson L.M. Jean-Philippe P. Palumbo P.
(2012)
BACKGROUND: Nevirapine-based antiretroviral therapy is the predominant (and often the only) regimen available for children in resource-limited settings. Nevirapine resistance after exposure to the drug for prevention of ...